Francesca Sánchez
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Antimicrobial Resistance in Staphylococcus
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Tuberculosis Research and Epidemiology 18
- HIV/AIDS drug development and treatment 3
- Epidemiology 16
- Pneumonia and Respiratory Infections 5
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Mycobacterium research and diagnosis 3
- Substance Abuse Treatment and Outcomes 2
- Co-authors
- Joan A. Caylà (11 shared papers)José Antônio Baddini Martínez (2 shared papers)Àlex Soriano (1 shared paper)José Mensa (1 shared paper)Manel Almela (1 shared paper)M. T. Jiménez de Anta (1 shared paper)Francesc Marco (1 shared paper)E Soriano (1 shared paper)
In The Last Decade
Francesca Sánchez
38 papers receiving 692 citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 385
- Clinical Biochemistry 84
- Applied Microbiology and Biotechnology 22
- Epidemiology 216
- Molecular Medicine 22
Countries citing papers authored by Francesca Sánchez
This map shows the geographic impact of Francesca Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Sánchez more than expected).
Fields of papers citing papers by Francesca Sánchez
This network shows the impact of papers produced by Francesca Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Sánchez. The network helps show where Francesca Sánchez may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesca Sánchez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 222 | |
| 2 | 2012 | 48 | |
| 3 | 2009 | 41 | |
| 4 | Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? | 2005 | 40 |
| 5 | 2002 | 38 | |
| 6 | 2009 | 37 | |
| 7 | 2015 | 35 | |
| 8 | 2006 | 33 | |
| 9 | 2008 | 27 | |
| 10 | 2015 | 23 | |
| 11 | 2013 | 17 | |
| 12 | 2008 | 15 | |
| 13 | 2016 | 12 | |
| 14 | 2016 | 12 | |
| 15 | 2019 | 11 | |
| 16 | 2002 | 11 | |
| 17 | 2010 | 10 | |
| 18 | 2018 | 9 | |
| 19 | 2011 | 7 | |
| 20 | 2007 | 7 |
About Francesca Sánchez
Francesca Sánchez is a scholar working on Infectious Diseases, Epidemiology, Surgery, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 40 papers that have together received 716 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (18 papers), Pneumonia and Respiratory Infections (5 papers), Infectious Diseases and Tuberculosis (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV/AIDS drug development and treatment (3 papers), Mycobacterium research and diagnosis (3 papers), Streptococcal Infections and Treatments (2 papers) and Substance Abuse Treatment and Outcomes (2 papers). The work is most often cited by research in Infectious Diseases (385 citations), Clinical Biochemistry (84 citations), Applied Microbiology and Biotechnology (22 citations), Epidemiology (216 citations) and Molecular Medicine (22 citations). Francesca Sánchez has collaborated with scholars based in Spain, Portugal and Chile. Frequent co-authors include Joan A. Caylà, José Antônio Baddini Martínez, Àlex Soriano, José Mensa, Manel Almela, M. T. Jiménez de Anta, Francesc Marco, E Soriano, A Moreno-Martínez and Carles Ariza. Their work appears in journals such as Journal of Clinical Microbiology, Medicine, Addictive Behaviors, BMC Public Health and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.